Learn About Large-Cell Immunoblastic Lymphoma
- Lymphoma, large-cell, immunoblastic
- Large cell immunoblastic lymphoma
City Of Hope - Duarte Main Campus
Alex Herrera is a Hematologist and a Hematologist Oncology provider in Duarte, CA. Dr. Herrera has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
City Of Hope Medical Foundation
Stephen Forman is a Hematologist in Duarte, California. Dr. Forman is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Duke Hematologic Malignancies Clinic
Suzanne Kirby is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Kirby is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kirby is currently accepting new patients.
Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center